Health Subcommittee, Energy and Commerce Committee
Introduced
In Committee
On Floor
Passed Chamber
Enacted
Second Chance at Life Act of 2019 This bill requires abortion providers administering chemical abortions to provide specified information about the possibility of reversing the effects of such procedure. Specifically, a patient must be informed at least 24 in advance that (1) reversing a chemical abortion may be possible after administering the first drug of a two-drug procedure and (2) additional information about chemical abortions is available through the Department of Health and Human Services. Further, after the first drug is administered, the physician must provide written discharge instructions to the patient that state it may be possible to reverse the abortion procedure before the second drug is taken, among other information. Such information also must be conspicuously posted inside the office or waiting area of clinics that provide chemical abortions. Abortion providers are not required to provide such information in the event that an abortion is necessary to save the life of a patient who is endangered due to a complication resulting from a pregnancy.
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the House Committee on Energy and Commerce.
Referred to the Subcommittee on Health.
Introduced in House
Referred to the House Committee on Energy and Commerce.
Referred to the Subcommittee on Health.
Health
AbortionCivil actions and liabilityFamily relationshipsGovernment information and archivesHealth facilities and institutionsHealth information and medical recordsHealth personnelMedical ethicsPrescription drugsSex and reproductive healthWomen's health
Second Chance at Life Act of 2019
USA116th CongressHR-2010| House
| Updated: 4/2/2019
Second Chance at Life Act of 2019 This bill requires abortion providers administering chemical abortions to provide specified information about the possibility of reversing the effects of such procedure. Specifically, a patient must be informed at least 24 in advance that (1) reversing a chemical abortion may be possible after administering the first drug of a two-drug procedure and (2) additional information about chemical abortions is available through the Department of Health and Human Services. Further, after the first drug is administered, the physician must provide written discharge instructions to the patient that state it may be possible to reverse the abortion procedure before the second drug is taken, among other information. Such information also must be conspicuously posted inside the office or waiting area of clinics that provide chemical abortions. Abortion providers are not required to provide such information in the event that an abortion is necessary to save the life of a patient who is endangered due to a complication resulting from a pregnancy.
Health Subcommittee, Energy and Commerce Committee
Health
Introduced
In Committee
On Floor
Passed Chamber
Enacted
AbortionCivil actions and liabilityFamily relationshipsGovernment information and archivesHealth facilities and institutionsHealth information and medical recordsHealth personnelMedical ethicsPrescription drugsSex and reproductive healthWomen's health